ETV6-ABL1-positive “chronic myeloid leukemia”: clinical and molecular response to tyrosine kinase inhibition

Lignende værker

• Recent advances in the treatment of acute myeloid leukemia
  af: Abdel-Wahab, Omar, et al.
  Udgivet: (2010)
• Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
  af: Abdel-Wahab, Omar, et al.
  Udgivet: (2013)
• An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia
  af: Zimmermannova, O, et al.
  Udgivet: (2017)
• Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
  af: Takeuchi, Asako, et al.
  Udgivet: (2020)
• Resistance to Imatinib in Patients with Chronic Myelogenous Leukemia and the Splice Variant BCR-ABL1(35INS)
  af: Berman, Ellin, et al.
  Udgivet: (2016)